PACRA Maintains the Entity Ratings of Descon Oxychem Limited

Descon Oxychem Limited (‘DOL’ or ‘the Company’), a listed concern, primarily engaged in the manufacturing, procurement, and sale of Hydrogen Peroxide (HPO) & allied products. Offering Technical, Aseptic, and Food Grades in different concentrations, DOL’s diverse HPO applications span key sectors including textile, mining, pulp & paper, water treatment, sugar, food & beverages, cosmetics, and poultry. The Company’s leading market position is supported by strong sponsorship and established client relationships. Notably, its sustainable, non-chlorine-based food-grade HPO offers substantial growth prospects within the food sector, requiring focused strategic development. Pakistan’s HPO market has transitioned from a monopoly to a two-player structure following Engro Polymer’s commissioning of a ~28,000 MT (50% concentration basis) plant in March 2025. Combined domestic production now covers ~60% of the total estimated demand of ~100,000 MT (50% concentration basis), with the remainder continuing to be met through imports. Engro’s incremental volumes have thus far largely displaced import share rather than directly eroding DOL’s domestic offtake. Imports, however, remain the most acute competitive threat, particularly from Bangladesh, whose structural cost advantages are further amplified by export schemes, which effectively subsidize import procurement and render import-origin HPO artificially cost-competitive against domestically produced volumes. During 9MFY26, DOL’s net revenues declined year-over-year, primarily driven by pricing pressure amid an influx of lower-priced imports, while volumetric performance remained broadly stable with near-full capacity utilization. Export revenues showed a gradual improvement, supported by the Company’s expanding international presence through its UAE subsidiary. Profitability metrics came under pressure during the period, reflecting a combination of industry-wide price erosion and elevated energy costs. Margins moderated across the board, as cost pressures outpaced pricing flexibility. To partially offset these pressures, the commissioning of a 2 MW solar power project is expected to provide energy cost savings, offering some relief given the share of power costs in the overall cost. The Company’s financial risk profile remains good, supported by strong coverage metrics, moderate cash generation, and a manageable working capital cycle. DOL’s capital structure is moderately leveraged, comprising a mix of long-term and short-term borrowings supported by a solid equity base. Going forward, DOL’s strategic move focuses on deepening penetration in higher-margin segments, expanding its export channel, and pursuing further cost optimization through energy efficiency and process improvements.
The ratings are dependent on DOL’s ability to sustain its market position amid intensifying competition and persistent import-driven pricing pressures. A recovery in selling prices, normalization of import cost distortions, and successful execution of the Company’s strategy to deepen penetration in higher-margin segments and expand its export channel shall remain critical. Maintenance of adequate cashflow, working capital cycle, and a prudent business risk profile will be equally imperative.

About the Entity
Descon Oxychem Limited (DOL), incorporated in 2004, commenced commercial production of Hydrogen Peroxide in March 2009. Descon Group, the principal sponsor of Descon Oxychem, holds a majority shareholding of 72.63% through associated companies, while a 27.37% stake is held by financial institutions and the general public. Descon Group has a strong foothold in the engineering business through its flagship company, Descon Engineering Limited. The Company’s Board, comprising eight members, is dominated by representatives of Descon Group. Mr. Faisal Dawood is the Chairman of the Board, while Mr. Yasir Siddique Sheikh is the CEO of the Company.